NCT05228470 2026-01-06A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.PfizerPhase 2 Completed39 enrolled 15 charts
NCT01169259 2025-11-06VITALBrigham and Women's HospitalPhase 3 Active not recruiting25,871 enrolled 38 charts